-
Amyloid Beta-Peptide (1-40) (human) Workflow
2026-08-29
Build more reproducible Alzheimer’s disease experiments by separating monomer-focused signaling assays from aggregation and fibril workflows. This practical guide uses Amyloid Beta-Peptide (1-40) (human) to connect peptide handling, microglial cytokine readouts, neurotoxicity mechanism investigation, and troubleshooting.
-
Small-Molecule Pancreatic Ductal Organoid Generation
2026-08-28
The reference study presents a small-molecule culture strategy that improves the initiation and long-term expansion of pancreatic ductal organoids while retaining heterogeneous exocrine cell features. Its Sox9-positive ductal origin and ductal–acinar composition make the system relevant to pancreatic disease modeling, including studies of ductal plasticity and pancreatic ductal adenocarcinoma.
-
Cl-Amidine as a Causal Probe in AML Research
2026-08-28
Cl-Amidine trifluoroacetate salt provides a selective way to interrogate PAD4-dependent histone citrullination while avoiding overinterpretation of AML transcriptional networks. This article connects the compound’s biochemical utility with LMO2/LDB1 findings and practical assay design.
-
Novobiocin, Membrane Synthesis, and Vacuoles
2026-08-27
This study shows that DNA replication is linked to plasma-membrane expansion and vacuole formation in Enterococcus faecalis protoplasts, even when cell division is prevented. By varying the timing of novobiocin exposure and removal, the authors identify a reversible, replication-dependent control point for protoplast enlargement.
-
Topotecan HCl: From DNA Lesions to Translation
2026-08-27
Topotecan HCl is more than a topoisomerase 1 inhibitor: it is a strategic model for connecting DNA damage, cell-killing kinetics, assay design, and translational oncology decisions.
-
AMG 487: A State-Aware CXCR3 Antagonist
2026-08-26
Explore how AMG 487 functions as a selective CXCR3 antagonist and how receptor pharmacology, macrophage state, LAMP1 signaling, and assay context shape experimental interpretation.
-
Ceftolozane-Tazobactam in Nosocomial Pneumonia
2026-08-26
This review explains how ceftolozane-tazobactam combines structural protection against AmpC β-lactamases with strong target activity against Pseudomonas aeruginosa. Its synthesis of susceptibility, PK/PD, resistance, and ASPECT-NP clinical evidence supports optimized treatment of hospital- and ventilator-associated pneumonia while highlighting important limits involving ESBLs, carbapenemases, and critically ill patients.
-
CKI 7 Dihydrochloride in CK1 Research
2026-08-25
Learn how to deploy CKI 7 dihydrochloride as a Casein kinase 1 inhibitor in enzyme, cell-signaling, circadian, and cancer workflows. The article connects practical CK1 perturbation with a recent MAPK10–KRT16 metastasis study while emphasizing controls, assay design, and troubleshooting.
-
Ribociclib Succinate: A Translational CDK4/6 Strategy
2026-08-25
Ribociclib succinate, also known as LEE011 succinate, offers translational researchers a selective way to connect CDK4/6 biology with cell-cycle assays, combination studies, and pH-aware experimental design.
-
Amyloid Beta-Peptide (1-40) Workflow Guide
2026-08-24
Build reproducible Aβ40 experiments by separating monomeric, oligomer-enriched, and fibril-forming peptide states. This workflow connects aggregation controls with microglial inflammatory assays, helping Alzheimer's disease researchers distinguish peptide-state biology from handling artifacts.
-
miR-3180 Rewires Lipid Metabolism in HCC
2026-08-24
Hong et al. identified miR-3180 as a regulator that suppresses hepatocellular carcinoma by simultaneously limiting SCD1-mediated fatty acid synthesis and CD36-mediated lipid uptake. The study combines patient-tissue analysis, molecular reporter assays, cellular phenotyping, lipid measurements, and xenograft models to connect this metabolic mechanism with tumor growth, migration, invasion, and metastasis.
-
HRP Proximity Labeling of Cell-Surface Proteins
2026-08-23
Wu and colleagues present a cell-type-specific HRP proximity-labeling workflow for profiling cell-surface proteins in mouse brain tissue. The protocol integrates AAV targeting, localized biotinylation, streptavidin enrichment, LC-MS/MS, and multiple quality-control steps, providing a practical framework for studying molecular interfaces in complex tissue.
-
Ceftolozane Sulfate: Assay-to-PK/PD Translation
2026-08-22
Ceftolozane sulfate links PBP3-directed bactericidal activity with resistance-aware susceptibility testing and PK/PD modeling. This guide shows how to translate MIC data from laboratory assays into interpretable neutropenic infection-model experiments.
-
Starvation, ER Ca2+, and Cell Fate in Bombyx mori
2026-08-22
A 2026 study in Bombyx mori fat body shows that sustained starvation shifts programmed cell death from an early autophagic response to calpain-associated apoptosis through an ER-Ca2+ signaling axis. Its use of metabolic, calcium, autophagy, and apoptosis readouts, together with 2-APB intervention, provides a mechanistic framework for studying nutrient stress and calcium-dependent cell fate.
-
Carfilzomib (PR-171): From Proteasome Stress to Translation
2026-08-21
Carfilzomib (PR-171) offers translational researchers a precise way to interrogate irreversible proteasome blockade, proteotoxic stress, and apoptosis. This article connects its chymotrypsin-like proteasome activity inhibition to emerging combination strategies involving ER stress and epigenetic therapy, while outlining practical validation, handling, and biomarker considerations.